Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Multidrug or pleiotropic resistance].

F Arvelo1, E Merentes, C Cotte

  • 1Laboratorio de Cultivo de Tejidos y Biología de Tumores, Facultad de Ciencias, U.C.V., Caracas, Venezuela.

Acta Cientifica Venezolana
|September 7, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Application of the Life Cycle Management of Analytical methods concept to a HPTLC-DPPH assay method for acteoside content in industrial extracts of Plantago lanceolata L.

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences·2021
Same author

Antarctic petrels 'on the ice rocks': wintering strategy of an Antarctic seabird.

Royal Society open science·2020
Same author

Heterogeneous expression of oncogenes in small-cell lung-cancer xenografts.

International journal of oncology·2011
Same author

HLA class I and neuroendocrine antigen expression in multidrug resistant small cell lung carcinoma cell lines.

International journal of oncology·2011
Same author

Mucinous differentiation features associated with hormonal escape in a human prostate cancer xenograft.

British journal of cancer·2004
Same author

[A new model of human prostate cancer, the PAC120 xenograft].

Pathologie-biologie·2003
Same journal

[Establisment of a genetic transformation method of coffee (Coffea arabica cv. Catimor) and incorporation of bar gene for ammonium glufosinate resistance].

Acta cientifica venezolana·2005
Same journal

[Effect of defatted corn germ flour and rice bran on some chemical, physical and sensory properties of sausages].

Acta cientifica venezolana·2005
Same journal

New late-intensification schedules for cancer treatments.

Acta cientifica venezolana·2005
Same journal

[Lipid profile from low socioeconomic level preschool children. Valencia, Venezuela].

Acta cientifica venezolana·2005
Same journal

Hematologic values among Warao indians with tuberculosis from the Orinoco Delta of Venezuela.

Acta cientifica venezolana·2005
Same journal

[Morphology and anatomy of the fruit and seed in development of Guarea macrophylla Vahl. (Meltaceae)].

Acta cientifica venezolana·2005
See all related articles

Multidrug resistance (MDR) in cancer, often caused by P-glycoprotein (encoded by the mdr1 gene), is a major treatment obstacle. Targeting P-glycoprotein activity and mdr1 gene regulation offers new therapeutic strategies for overcoming cancer drug resistance.

Area of Science:

  • Oncology
  • Molecular Biology
  • Pharmacology

Background:

  • Cytotoxic drug resistance in cancer is a significant barrier to effective treatment.
  • Intrinsic resistance of tumor cells contributes to therapeutic failure.
  • P-glycoprotein, a membrane glycoprotein, is associated with multidrug resistance (MDR) phenotype.

Purpose of the Study:

  • To review recent developments concerning P-glycoprotein and the mdr1 gene in cancer drug resistance.
  • To explore the role of P-glycoprotein in drug efflux.
  • To identify potential therapeutic targets for overcoming MDR.

Main Methods:

  • Review of scientific literature on P-glycoprotein, mdr1 gene, and multidrug resistance.
  • Analysis of studies investigating the function of P-glycoprotein in drug-resistant cell lines and tumors.

Related Experiment Videos

  • Examination of research on the genetic regulation of the mdr1 gene.

    • Main Results:

    • P-glycoprotein overexpression is linked to MDR in various drug-resistant tumoral cell lines.
    • The human mdr1 gene encodes P-glycoprotein, implicated in drug efflux.
    • Frequent mdr1 gene overexpression in clinically resistant tumors suggests its role in treatment failure.

    Conclusions:

    • P-glycoprotein plays a crucial role in the multidrug resistance phenotype.
    • The mdr1 gene's overexpression is a potential cause of treatment failure in human cancers.
    • Modulating P-glycoprotein activity and mdr1 gene regulation presents promising avenues for novel anticancer therapies.